Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A Minority Interest

The latest minority interest for FBIOP is $42M as of June 2026. That compares with $-6.5M in the prior-year period — up 741.3% year over year. Investors often review this figure alongside Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's historical trend and sector peers before judging valuation or financial health.

Over the past year, FBIOP's minority interest moved from $-6.5M to $42M — a 741.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's operating scale or balance-sheet position.

A minority interest figure of $42M for FBIOP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FBIOP's minority interest ($42M), review year-over-year change from $-6.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's minority interest against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.